Noninvasive methods for quantitating blood time-activity curves from mouse PET images obtained with fluorine-18-fluorodeoxyglucose

Journal of Nuclear Medicine

Volumn 39, Issue 4, 1998, Pages 729-734

  Green, Leeta A ^b   Gambhir, Sanjiv S ^a   Srinivasan, Ashok ^b   Banerjee, Pranab K ^b   Hoh, Carl K ^b   Cherry, Simon R ^b   Sharfstein, Susan ^b   Barrio, Jorge R ^b   Herschman, Harvey R ^b   Phelps, Michael E ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

Blood time activity curves; Fluorine 18 fluorodeoxyglucose; Mice; PET; Quantitation

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOWMETRY; BLOOD SAMPLING; GEOMETRY; IMAGE ANALYSIS; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RELIABILITY; THEORY;

ANIMALS; BRAIN; FLUORODEOXYGLUCOSE F18; HEART; LIVER; MICE; MICE, INBRED C3H; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031900171     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Srinivasan A, Gambhir SS, Green AL, et al. A PET reporter gene (PRG)/PET reporter probe (PRP) technology for repeatedly imaging gene expression in living animals [Abstract]. J Nucl Med 1996;37(suppl):107P-108P.
2. Tjuvajev J, Finn R, Watanabe K, et al. Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: a potential method for monitoring gene therapy. Cancer Res 1996;56:4087-4095.
3. Kallinowski F, Brownell AL, Vaupel P, Brownell GL. Combined tissue oxygen tension measurement and positron emission tomography studies on glucose utilization in oncogene-transformed cell line tumour xenografts in nude mice. Br J Radial 1991;64:350-359.
4. Hawkins RA, Choi Y, Scates S, et al. An animal model for in vivo evaluation of tumor glycolytic rates with positron emission tomography. J Surg Oncol 1993;53:104-109.
5. Silver LM. Mouse genetics: concepts and applications. New York: Oxford University Press; 1995:12-13.
6. Boyd AL, Samid D. Review: molecular biology of transgenic animals. J Anim Sci 1993;3:1-9.
7. Bradley A, Hasty P, Davis A, Ramirez-Solis R. Modifying the mouse: design and desire. Biotechnology 1992;10:534-539.
8. Mullins JJ, Mullins LJ. Transgenesis in nonmurine species. Hypertension 1993;22: 630-633.
9. Mullins LJ, Mullins JJ. Transgenesis in the rat and larger mammals. J Clin Invest 1996;97:1557-1560.
10. Bulte JW, Go KG, Zuiderveen F, The TH, de Leij L. Intracerebral and subcutaneous xenografts of human SCLC in the nude rat: comparison of monoclonal antibody localization and tumor infiltrating lymphocytes. J Neurooncol 1993;16:11-18.
11. DiResta GR, Lee J, Larson SM, Arbit E. Characterization of neuroblastoma xenograft in rat flank. I. Growth, interstitial fluid pressure, and interstitial fluid velocity distribution profiles. Microvasc Res 1993;46:158-177.
12. 18F)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 1979;6:371-388.
13. Huang SC, Phelps ME, Hoffman EJ, Sideris K, Selin CJ, Kuhl DE. Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol 1980;238:E69-E82.
14. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 1977;28:897-916.
15. Davies B, Morris T. Physiological parameters in laboratory animals and humans. Pharm Res 1993;10:1093-1095.
16. Weinberg IN, Huang SC, Hoffinan EJ, et al. Validation of PET-acquired input functions for cardiac studies. J Nucl Med 1988;29:241-247.
17. Gambhir SS, Schwaiger M, Huang SC, et al. Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose. J Nucl Med 1989;30:359-366.
18. 11C]hexanoate as a PET tracer of fatty acid metabolism. Ann Nucl Med 1995;9:51-57.
19. Choi Y, Hawkins RA, Huang SC, et al. Evaluation of the effect of glucose ingestion and kinetic model configurations of FDG in the normal liver. J Nucl Med 1994;35: 818-823.
20. 18F]2-deoxy-2-fluoro-D-glucose. J Nucl Med 1978;19:1154-1161.
21. 18F]fluoro-D-glucose in human cancers heterotransplanted in nude mice: comparison between histology and glycolytic status. J Nucl Med 1994;35:97-103.
22. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983;3:1-7.
23. Hoffman EJ, Huang SC, Phelps ME. Quantitation in positron emission computed tomography I. Effects of object size. J Comput Assist Tomogr 1979;3:299-308.
24. Larsson B, Ullber S. Whole-body autoradiography. J Histochem Cytochem 1981;29: 216-225.
25. Gambhir SS. Quantisation of the physical factors affecting the tracer kinetic modeling of cardiac positron emission tomography data [PhD thesis]. Los Angeles; University of California; 1990.
26. 18F]-fluoro-2-deoxy-D-glucose using amino polyether supported nucleophilic substitution. J Nucl Med 1986;27:235-238.
27. Cutler D, Cherry SR, Hoffman E, Digby W, Phelps M. Design features and performance of a PET system for animal research. J Nucl Med 1992;33:595-604.
28. Grazer, FM. Technic for intravascular injection and bleeding of newborn rats and mice. Proc Soc Exp Biol Med 1958;99:407-409.
29. Ross S. Introduction to probability and statistics for engineers and scientists. New York: John Wiley and Sons; 1987:226-227,306-316.
30. Storey RH, Wish L, Furth J. Organ erythrocyte and plasma volumes of tumor-bearing mice: the oligemia of neoplasms. Cancer Res 1951;11:943-947.